SecA Is Required for the Insertion of Inner Membrane Proteins Targeted by the Escherichia coli Signal Recognition Particle*

Hai-Yan Qi and Harris D. BernsteinDagger

From the Genetics and Biochemistry Branch, NIDDK, National Institutes of Health, Bethesda, Maryland 20892-1810

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Recent work has demonstrated that the signal recognition particle (SRP) is required for the efficient insertion of many proteins into the Escherichia coli inner membrane (IM). Based on an analogy to eukaryotic SRP, it is likely that bacterial SRP binds to inner membrane proteins (IMPs) co-translationally and then targets them to protein transport channels ("translocons"). Here we present evidence that SecA, which has previously been shown to facilitate the export of proteins targeted in a post-translational fashion, is also required for the membrane insertion of proteins targeted by SRP. The introduction of SecA mutations into strains that have modest SRP deficiencies produced a synthetic lethal effect, suggesting that SecA and SRP might function in the same biochemical pathway. Consistent with this explanation, depletion of SecA by inactivating a temperature-sensitive amber suppressor in a secAam strain completely blocked the membrane insertion of AcrB, a protein that is targeted by SRP. In the absence of substantial SecA, pulse-labeled AcrB was retained in the cytoplasm even after a prolonged chase period and was eventually degraded. Although protein export was also severely impaired by SecA depletion, the observation that more than 20% of the OmpA molecules were translocated properly showed that translocons were still active. Taken together, these results imply that SecA plays a much broader role in the transport of proteins across the E. coli IM than has been previously recognized.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Proteins that are destined to be translocated across or inserted into the bacterial inner membrane (IM)1 are targeted to transport sites by multiple mechanisms. In Escherichia coli, many secreted proteins are targeted to the IM by molecular chaperones such as SecB, which keep them in a loosely folded, translocation-competent conformation (1, 2). The chaperone-based targeting pathways promote the translocation of fully synthesized proteins in vitro and probably also function in a post-translational fashion at least to some extent in vivo (3, 4). By contrast, recent studies have suggested that a variety of inner membrane proteins (IMPs) are targeted to the membrane by an essential ribonucleoprotein complex that is closely related to the eukaryotic signal recognition particle (SRP) (5-7). In mammalian cells, SRP is a complex composed of six polypeptides and a single RNA that targets proteins to the secretory pathway in a strictly co-translational fashion (reviewed in Ref. 8). The 54 kDa subunit of SRP (SRP54) binds to signal sequences of nascent polypeptides and guides ribosome-nascent chain complexes to transport sites in the endoplasmic reticulum (ER) via an interaction with the membrane-bound SRP receptor. Although the SRP found in E. coli and many other bacterial species contains only a single protein (a homolog of SRP54 called "Ffh") and a small RNA ("4.5 S RNA") (9), many aspects of its function appear to be conserved, including co-translational binding to substrates (10) and a specific interaction with a homolog of the SRP receptor ("FtsY") (11).

All of the different targeting pathways appear to converge at the IM. Both exported proteins and IMPs are transported by a common translocation channel or "translocon" composed of a phylogenetically conserved heterotrimer called the SecYEG complex, which is closely related to the Sec61p complex found in the eukaryotic ER (reviewed in Ref. 12). Bacteria differ from eukaryotes, however, in that they have a unique peripheral membrane protein called SecA that interacts with SecY (13, 14) and that plays an essential role in protein export (15, 16). SecA acts as a molecular motor that binds to SecB-preprotein complexes in the cytoplasm (17) and then uses the energy of ATP hydrolysis to catalyze post-translational translocation across the cytoplasmic membrane (18). Following translocation, SecA is released from the membrane (19). Relatively little is known about the role of SecA in IMP insertion, and its role in transporting proteins targeted by the SRP pathway is particularly unclear. The insertion of some IMPs, but not others, has been proposed to be SecA-dependent (e.g. Refs. 20-24), but the SecA dependence does not correlate well with SRP dependence. Moreover, in all of the studies on IMP insertion, SecA activity has been blocked by adding sodium azide, a weak inhibitor of the SecA ATPase, or by shifting strains containing the temperature-sensitive secA51ts allele to high temperature. Because ATP binding and hydrolysis regulates the affinity of SecA for different components of the system, azide treatment may interfere with the normal cycling of SecA and may therefore inhibit IMP insertion by an indirect mechanism. Likewise, the SecA51(Ts) protein becomes trapped on the IM above 33 °C (25) and may block IMP insertion by simply interfering with the docking of ribosomes. Indeed recent studies strongly suggest that the use of sodium azide and temperature-sensitive sec alleles can produce misleading results (22, 26).

To circumvent the problems associated with conditional alleles and inhibitors of SecA function, we used a novel approach to investigate the role of SecA in the membrane insertion of SRP substrates. Initially we tested for a genetic interaction between SRP and SecA using a synthetic lethality assay. The results from these experiments raised the possibility that SRP and SecA function in the same biochemical pathway. To test this idea directly, we examined the effect of SecA depletion on the membrane insertion of an SRP substrate, AcrB. In these experiments we used a strain that contains a secAam mutation and a temperature-sensitive amber suppressor. At low temperature full-length SecA protein is synthesized, but at high temperature only a small unstable fragment of the protein is produced (16). We found that after SecA depletion AcrB was quantitatively retained in the cytosol, where it was eventually degraded. Surprisingly, we found that although SecA depletion also had a profound effect on protein export, a fraction of at least one protein was still properly translocated. These results demonstrate that SecA function is at least as important for the insertion of IMPs targeted by SRP as for protein export and suggest that SecA plays a role in the transport of both co-translationally and post-translationally targeted proteins.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Bacterial Strains and Manipulations-- Strains HDB90 (secA+ zab::Tn10), HDB91 (secA450 zab::Tn10), and HDB92 (secA51ts zab::Tn10) were constructed by introducing the secA mutations from MM52 and EE450 (27, 28) into HDB45 (MC4100 pHDB4 ffh::kan) (6) by P1 transduction. Strains BA13 (MC4100 supFts trpam secA13am zch::Tn10) and DO251 (MC4100 supFts leu::Tn5 zch::Tn10) were obtained from Dr. Don Oliver. Media preparation and bacterial manipulations were performed according to standard methods (28). Selective media contained 100 µg/ml ampicillin or 40 µg/ml chloramphenicol.

Plasmid Construction-- Amino acids 266-1049 were deleted from AcrB by excising an NruI-SalI fragment from plasmid S215 (6) and repairing the ends with DNA polymerase (Klenow fragment) to generate plasmid S215Delta 2. To create a fusion of alkaline phosphatase (AP) with AcrB at amino acid 265 (pJN4), S215Delta 2 was digested with SalI and ligated to a BsiHKAI-XhoI fragment of pHI-1 containing the AP gene (30) using the oligonucleotide adapters 5'-CCGCCGGGTGCAGTAATATCGCCT-3' and 5'-TCGAAGGCGATATTACTGCACCCGGCGGTGCT-3'.2 A derivative of pJN4 in which the AP fusion was subcloned into pACYC184 (pJN6) was used for the experiments described here. A pACYC184 derivative containing the AcrB 576-AP fusion (pNU88) and plasmid pAP-1 have been described (6, 31).

Pulse-Chase Labeling, Immunoprecipitations, and Western Blots-- Cells were grown overnight at 30 °C in M9 medium containing 0.4% glucose and 40 µg/ml L-amino acids, excluding methionine and cysteine. Cultures were then diluted into fresh medium at an optical density (A550) of 0.02 and grown to an OD of 0.05 at 30 °C. Each culture was then divided in half. One-half was maintained at 30 °C while the other was shifted to 41 °C. At various times after the temperature shift, cells were subjected to pulse-chase labeling and processed essentially as described (6). In some experiments, spheroplasts were divided into two portions, one of which was treated with proteinase K. Proteins were collected by trichloroacetic acid precipitation, and immunoprecipitations were performed as described (6, 31). To provide an internal standard, chloramphenicol acetyltransferase (CAT) was immunoprecipitated from all samples. To measure levels of SecA and SecY, portions of each culture were removed and cold trichloroacetic acid was added to a final concentration of 10%. trichloroacetic acid precipitates were collected by centrifugation, and Western blotting was performed as described (6). The antibodies against various proteins that were used in this study were obtained from 5 Prime right-arrow 3 Prime, Inc., Boulder, CO (AP, CAT), Dr. Jon Beckwith (ribose-binding protein (RBP), OmpA), Dr. Don Oliver (SecA) and Dr. Koreaki Ito (SecY).

Subcellular Fractionation-- Radiolabeled cells were resuspended in phosphate-buffered saline and lysed by ultrasonic treatment using a Heat Systems XL-2020 sonicator. A "total" cell lysate was obtained after removing unbroken cells by centrifugation at 3,000 × g for 10 min in a Sorvall HS-4 rotor. Cell envelopes were separated from the cytosol by centrifugation at 100,000 × g for 30 min at 4 °C in a Beckman Optima TLX tabletop ultracentrifuge. To separate the outer and inner membranes, the pellet was resuspended in 3 mM EDTA (pH 7.2) and incubated in the presence of 0.5% Sarkosyl for 20 min at room temperature (32). This mixture was recentrifuged at 100,000 × g for 30 min at 4 °C. The pellet, which contained outer membranes, was resuspended in 50 mM Tris-HCl (pH 8.0), 10 mM EDTA. Proteins were collected by trichloroacetic acid precipitation and immunoprecipitations were performed as described above.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

SecA Mutations Are Lethal in Strains That Have SRP Deficiencies-- Although cells can generally tolerate slight deficiencies in essential biochemical pathways, it has often been observed that combining two deficiencies in the same pathway has a synergistic effect that leads to cell death (33). Thus, if SRP and SecA are required in successive steps of IMP insertion, then reduction in the activity of each of these factors might produce similar physiological effects that together would be lethal. To test the effect of reducing SRP and SecA activity simultaneously, we constructed strains HDB90 (secA+), HDB91 (secA450), and HDB92 (secA51ts) in which the expression of ffh is regulated by the trc promoter. Cells were plated on LB agar containing various amounts of IPTG and incubated at temperatures that are permissive for growth. Based on previous studies performed with the parent strain (HDB45), it was expected that a near wild-type level of Ffh would be produced in the presence of 10 µM IPTG (6). Growth of HDB91 cells at 37 °C and of HDB92 cells at 30 °C was observed on LB plates containing this concentration of inducer (Fig. 1, A and B). When the level of inducer and therefore the level of Ffh was slightly reduced, however, strong growth defects were observed; HDB91 and HDB92 did not grow at all on plates containing 2 µM IPTG and no IPTG, respectively. HDB90 cells grew about as well on the plates containing reduced levels of inducer as on plates containing 10 µM IPTG. These results demonstrate that reduction in SRP concentration in cells that contain SecA mutations produces a synthetic lethal effect and therefore raise the possibility that SecA participates in the insertion of SRP substrates.


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 1.   Ffh deficiencies are lethal in secA mutant strains. HDB90 (secA+), HDB91 (secA450), and HDB92 (secA51ts) cells, which contain the ffh gene under control of the trc promoter, were streaked on LB agar containing the indicated concentration of IPTG. At IPTG concentrations below 10 µM, the cells contain less Ffh than isogenic ffh+ strains. Plates were incubated at 37 °C for 22 h (A) or 30 °C for 28 h (B).

SecA Depletion Abolishes the Insertion of AcrB-- We next used a protease protection assay to study the effect of SecA depletion on the insertion of the SRP substrate AcrB. In this assay, protease treatment releases the AP domain from IMP-AP fusion protein molecules that are properly inserted into the IM but not from those that are retained in the cytoplasm (34). This method has been used to show that inhibition of the SRP pathway sharply reduces the membrane insertion of both the polytopic AcrB 576-AP fusion and the bitopic AcrB 265-AP fusion (6).2 Strains BA13 (secAam supFts) and DO251 (secA+ supFts) were first transformed with plasmids that encode the AP fusions. Cells were then grown in defined minimal medium at 30 °C, at which temperature the amber suppressor in BA13 is stable. Under these conditions the two strains grew equally well (Fig. 2A, diamonds and circles) and contained similar amounts of SecA (Fig. 2B, lanes 3-4) as shown by Western blot. When the cells reached early log phase, half of each culture was removed and incubated at 41 °C, a temperature at which the amber suppressor is denatured (Fig. 2A, solid arrow). Effective dilution of the residual SecA protein required 3 h (Fig. 2B, lane 1) at which point cell growth began to decline (Fig. 2A, dashed arrow). Portions of each culture were removed at various times after the temperature shift and radiolabeled with [35S]methionine and [35S]cysteine. The cells were harvested, spheroplasts were generated and treated with protease, and the released AP plus any protease-protected AP fusion protein that remained was immunoprecipitated with anti-AP antibodies.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 2.   Growth of a secAam strain and depletion of SecA at high temperature. Panel A, BA13 (supF (Ts) secA13 (Am)) and DO251 (supF (Ts) secA+) cells were transformed with plasmid pJN6 or pNU88 and grown in minimal medium at 30 °C (see "Experimental Procedures"). When the optical density (A550) reached 0.05 (filled arrow), the cultures were divided and half of the cells were placed at 41 °C. The growth of BA13 (---) and DO251 (black-diamond  - - black-diamond ) maintained at 30 °C and BA13 (black-square - black-square) and DO251 (black-triangle ... black-triangle) after the shift to 41 °C is shown. Panel B, the level of SecA in BA13 cells growing at 41 °C (lane 1) or 30 °C (lane 3) and DO251 cells growing at 41 °C (lane 2) or 30 °C (lane 4) was measured by Western blot 3 h after the cultures were divided (panel A, dashed arrow). An equal amount of protein was loaded in each lane.

We found that depletion of SecA had a profound effect on the membrane insertion of the AcrB-AP fusion proteins. A partial block of AcrB insertion was observed by 1.5 h after the shift (data not shown), but by 3 h a virtually complete block was observed. All of the pulse-labeled AcrB 265-AP fusion protein in BA13 cells was protease-protected following a 2-min chase, indicating that the protein was retained in the cytoplasm (Fig. 3A, lanes 1-2). Even after a 30-min chase, little or no fusion protein was inserted into the membrane (Fig. 3A, lane 4). Because the fusion protein that remained in the cytoplasm was slowly degraded, only about 50% of the radiolabeled molecules were immunoprecipitated at this time point. By contrast, the AcrB 265-AP fusion protein was inserted efficiently into the IM of BA13 cells grown continuously at 30 °C and DO251 grown at either 30 or 41 °C (Fig. 3A, lanes 5-16) as indicated by the complete susceptibility of the AP domain to proteolysis at all time points. Similar results were obtained in experiments in which the insertion of the AcrB 576-AP fusion was examined. At 41 °C, only protease-protected pulse-labeled fusion protein was immunoprecipitated from BA13 cells following a 2-min chase (Fig. 3A, lanes 1-2). After longer chase times, very little fusion protein was isolated from either untreated or protease-treated spheroplasts (Fig. 3B, lanes 1-2) due to rapid degradation of the protein in the cytoplasm. Quantitative insertion of the AcrB 576-AP fusion was observed in BA13 cells grown at 30 °C and in DO251 cells at both high and low temperature (Fig. 3A, lanes 5-16), and the membrane-bound form of the protein was stable (Fig. 3B, lanes 3-8).


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 3.   SecA depletion completely blocks the insertion of AcrB-AP fusion proteins. BA13 and DO251 transformed with plasmid pJN6 or pNU88 were grown as described in the legend to Fig. 2. Panel A, the insertion of AcrB 265-AP or AcrB 576-AP in cells grown at 41 °C for 3 h or maintained continuously at 30 °C was examined by pulse-chase analysis. AP-containing polypeptides were immunoprecipitated from untreated spheroplasts (lanes 1, 8, 9, and 16) or from spheroplasts that were treated with proteinase K (lanes 2-6 and 10-15). The length of the chase is indicated. Panel B, the stability of AcrB 576-AP was measured by immunoprecipitating the fusion protein from untreated spheroplasts generated in the experiment described in panel A.

To confirm that the protease resistance of the AcrB-AP fusion proteins was due to retention in the cytoplasm, we examined their localization in more detail by cell fractionation. BA13 and DO251 cells were grown at 30 °C as described above and shifted to 41 °C for 3 h. The cells were then pulse-labeled and harvested following a 10-min chase. Cell extracts were prepared by sonication, and membranes were isolated by high speed centrifugation. About 80-90% of the AcrB 265-AP fusion protein in BA13 cells was found in the high speed supernatant and cofractionated with the cytoplasmic protein CAT (Fig. 4A). By contrast, almost all of the fusion protein in DO251 cells was found in the membrane fraction. Similar results were obtained when the cells were spheroplasted and lysed by hypotonic shock using established methods (data not shown). These results demonstrate directly that depletion of SecA prevents the integration of SRP substrates into the IM.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 4.   Intracellular localization of AcrB 265-AP and OmpA after SecA depletion. BA13 and DO251 transformed with plasmid pJN6 were grown at 30 °C as described in the legend to Fig. 2. When the A550 reached 0.05, cultures were shifted to 41 °C and incubated for 3 h. Aliquots were pulse-labeled and subjected to a 10-min chase. Cell fractions were obtained as described under "Experimental Procedures." Panel A, AcrB 265-AP and CAT were immunoprecipitated from the total cell extract (T, lane 1), the cytoplasm (C, lane 2) and total membranes (M, lane 3). Panel B, OmpA and its precursor (pro-OmpA) were immunoprecipitated from the total cell extract (T, lane 1), the cytoplasm (C, lane 2), inner membranes (IM, lane 3) and outer membranes (OM, lane 4).

SecA Depletion Inhibits but Does Not Completely Abolish Protein Export-- Although the effect of inhibiting SecA activity on protein export has been studied extensively in vivo, most experiments have involved treating cells with sodium azide or shifting strains containing the secA51ts allele to the nonpermissive temperature. To test the effect of SecA depletion on protein export, BA13 and DO251 cells were first transformed with a plasmid expressing an AcrB-AP fusion or with plasmid pAP-1 (31). Cells were then grown and radiolabeled as described above, and AP, RBP, and OmpA were immunoprecipitated from samples that were not treated with proteinase K. Consistent with previous studies on SecA function, the export of AP and RBP was completely blocked by SecA depletion. None of the radiolabeled precursor was converted to the mature form in BA13 cells grown at 41 °C even after a 30-min chase (Fig. 5, lanes 1-3). Like the AcrB-AP fusion proteins, pre-AP retained in the cytoplasm (but not pre-RBP) was slowly degraded during the long chase period. By contrast, rapid export of both AP and RBP from BA13 grown at 30 °C or from DO251 cells grown at either high and low temperature was indicated by the complete processing of the radiolabeled precursors within 2 min (Fig. 5, lanes 4-12). Export of OmpA was also significantly inhibited by SecA depletion, but surprisingly a small fraction of the protein appeared to be slowly translocated across the inner membrane (Fig. 5, lanes 1-3). Only about 12% of the protein was processed after a 2-min chase, but after 30 min, more than 20% of the pro-OmpA was converted to OmpA. The remainder of the pro-OmpA was gradually degraded in the cytoplasm.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 5.   Depletion of SecA blocks protein export. BA13 and DO251 were transformed with pAP-1 or pJN6. Cells were grown as described in the legend to Fig. 2. AP, RBP, and OmpA were immunoprecipitated from radiolabeled BA13 and DO251 grown at 41 °C for 3 h (lanes 1-6) or maintained at 30 °C (lanes 7-12). The length of the chase is indicated.

We next performed cell fractionation experiments to confirm that the processing of OmpA observed after SecA depletion was due to proper translocation and insertion of the protein into the outer membrane (OM). Pulse-labeled BA13 and DO251 cells that had been incubated at 41 °C for 3 h were harvested after a 10-min chase. Cell membranes were separated from the cytoplasm by centrifugation and then further divided into IM and OM fractions. The AcrB-AP fusion protein was used as a marker to validate the membrane fractionation method (data not shown). OmpA was then immunoprecipitated from each cell fraction. In BA13 cells, all of the processed OmpA was correctly localized to the OM (Fig. 4B, lanes 1 and 4). Most of the pro-OmpA remained in the cytoplasm, although a small portion was isolated in the IM fraction (Fig. 4B, lanes 1-3). As expected, all of the OmpA in DO251 cells was properly processed and inserted into the OM (Fig. 4B, lanes 1 and 4). Taken together, these results show that OmpA is accurately transported across the IM (albeit with reduced efficiency) even after a severe reduction in the level of SecA. Thus the IMP insertion defects described above are not due to a nonspecific inactivation of translocons following SecA depletion.

To determine whether SecA depletion affected translocon stability, we measured the SecY levels in BA13 and DO251 cells grown at 30 °C and 41 °C by Western blot. A similar amount of SecY was present in each strain at both temperatures (Fig. 6, lanes 2-5). This result strongly suggests that the AcrB insertion block observed in the absence of SecA was not caused by a loss of protein transport capacity.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 6.   Depletion of SecA does not destabilize the SecY complex. BA13 and DO251 cells were grown as described in the legend to Fig. 2. The intracellular level of SecY in an equal number of DO251 and BA13 cells grown at 41 °C for 3 h (lanes 1-3) or maintained continuously at 30 °C (lanes 4 and 5) was measured by Western blot. An extract from DO251 cells that overproduce translocon proteins was loaded in lane 1 to provide a marker for the position of SecY (*).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In the experiments reported here we have obtained strong evidence that SecA plays an essential role in the membrane insertion of proteins targeted by SRP in E. coli. In an initial genetic test, we found that slight Ffh deficiencies are lethal in SecA mutant strains. This observation indicated that SecA and SRP are likely to function in either the same or in parallel biochemical pathways. To distinguish between these two possibilities, we analyzed the insertion of a model SRP substrate, AcrB, in cells that had normal levels of SRP but reduced levels of SecA activity. To avoid possible artifacts associated with conditional alleles and metabolic inhibitors in these experiments, we used a strain in which SecA can be depleted. The observation that the insertion of both bitopic and polytopic AcrB-AP fusion proteins was quantitatively blocked by SecA depletion strongly supports the hypothesis that SecA is required for the insertion of SRP substrates. In light of evidence that SRP targets proteins to the IM cotranslationally, the simplest explanation of the cell fractionation data is that the SecA dependence is dictated by the AcrB moeity of the fusion proteins. If SecA were required only for the transport of the AP domain, then the fusion proteins would have been expected to fractionate with cell membranes. Nevertheless, we cannot completely exclude the possibility that attachment of an AP domain to an IMP influences the SecA-dependence of its biogenesis. Interestingly, results from a recent biochemical study (35) are consistent with the conclusion that SecA functions downstream from SRP in the IMP insertion process. Nascent IMPs that were bound to E. coli SRP were released by the addition of FtsY and then, in the presence of membrane vesicles, transferred to the translocon. Although some of the nascent chains were cross-linked to SecY, a much larger fraction was cross-linked to SecA. Our results suggest that the proximity of the nascent chain to SecA that is implied by this study may have an important functional significance.

The finding that SecA is required for the insertion of SRP substrates in E. coli is surprising in light of previous studies on the eukaryotic SRP pathway. In mammalian cells a tight seal between the ribosome and the translocon is generally formed after nascent chains are targeted to the ER by SRP (36). Continued elongation of the nascent chain is thought to be sufficient to push the polypeptide through the translocon. If the molecular mechanisms of translocation are conserved in bacteria, then motor proteins such as SecA would not be expected to participate in the transport of SRP substrates. Thus our results, together with the observation that only the core components of the translocon are evolutionarily conserved, suggest that there are significant differences between eukaryotic and prokaryotic translocation systems. It is possible that the composition of the translocon or of the IM itself hinders the formation of a tight ribosome-translocon junction or necessitates the use of a molecular motor to drive proteins across the membrane. Dissociation of the ribosome from the translocon has been observed in mammalian cells under some circumstances (37), and this phenomenon might be more predominant in bacterial cells. If so, then the motor function of SecA may be required to ensure continuous transport of nascent chains across the membrane.

An alternative explanation of our results that would be consistent with the formation of a tight ribosome-translocon junction is that SecA promotes the insertion of SRP substrates by a mechanism that does not depend on its motor activity. Extensive analysis of protein translocation in vitro has clearly shown that SecA uses the energy of ATP hydrolysis to facilitate post-translational translocation, but the data do not rule out the possibility that SecA has additional functions. Recently it has been shown that the ER lumenal protein BiP maintains the permeability barrier of the ER by sealing nontranslocating Sec61p complexes (38). It is conceivable that inactive translocons in bacteria are sealed by a different mechanism (no BiP equivalent has yet been identified) and that SecA triggers conformational changes that are required to initiate both protein translocation and IMP insertion. The observation that SecY is stable after substantial SecA depletion suggests that SecA is not required, however, to maintain the structural integrity of the translocon.

In addition to providing evidence that SecA is required for the insertion of SRP substrates, our experiments also yielded several unanticipated results. Given that inhibition of the SRP pathway only partially blocks the insertion of all substrates that have been tested (5, 6, 26),2 the observation that SecA depletion completely abolished the insertion of AcrB is striking. This result suggests that the insertion of AcrB is SecA-dependent regardless of the mechanism by which it is targeted to the translocon. Furthermore, although our data are consistent with other types of evidence indicating that SecA is essential for protein export, the slow translocation of OmpA observed after SecA was nearly completely depleted was very surprising. OmpA is often used as a model protein for in vitro translocation studies, and its transport into membrane vesicles is strictly dependent on SecA (16). The relative insensitivity of OmpA export to reduced SecA concentrations suggests that it has an atypical ability to persist in a transport-competent form or that it has a much higher affinity for SecA than most other periplasmic and membrane proteins. In either case, the unexpected behavior of OmpA in these experiments, together with the finding that SecA is required for the transport of a wider range of proteins than previously suspected, suggests that many aspects of SecA function remain to be elucidated.

    ACKNOWLEDGEMENTS

We thank Linda Diehl for excellent technical assistance, Jon Beckwith, John Newitt, Nancy Trun, and Nancy Ulbrandt for helpful discussions and comments on the manuscript, and Jon Beckwith, Koreaki Ito, Catherine Lee, and Don Oliver for gifts of strains and antibodies.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: National Institutes of Health, Bldg. 10, Rm. 9D-20, Bethesda, MD 20892-1810. Tel.: 301-402-4770; Fax: 301-402-0387; E-mail: harris_bernstein{at}nih.gov.

2 J. A. Newitt, N. D. Ulbrandt, and H. D. Bernstein, manuscript submitted.

    ABBREVIATIONS

The abbreviations used are: IM, inner membrane; AP, alkaline phosphatase; CAT, chloramphenicol acetyl transferase; IMP, inner membrane protein; IPTG, isopropylthiogalactoside; OM, outer membrane; RBP, ribose-binding protein; SRP, signal recognition particle; ER, endoplasmic reticulum.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
  1. Kumamoto, C. A., and Beckwith, J. (1985) J. Bacteriol. 163, 267-274[Medline] [Order article via Infotrieve]
  2. Collier, D. N., Bankaitis, V. A., Weiss, J. B., and Bassford, P. J., Jr. (1988) Cell 53, 273-283[Medline] [Order article via Infotrieve]
  3. Koshland, D., and Botstein, D. (1982) Cell 30, 893-902[Medline] [Order article via Infotrieve]
  4. Randall, L. L. (1983) Cell 22, 231-240
  5. de Gier, J. W., Mansournia, P., Valent, Q. A., Phillips, G. J., Luirink, J., and von Heijne, G. (1996) FEBS Lett. 399, 307-309[CrossRef][Medline] [Order article via Infotrieve]
  6. Ulbrandt, N. D., Newitt, J. A., and Bernstein, H. D. (1997) Cell 88, 187-196[Medline] [Order article via Infotrieve]
  7. Seluanov, A., and Bibi, E. (1997) J. Biol. Chem. 272, 2053-2055[Abstract/Free Full Text]
  8. Walter, P., and Johnson, A. E. (1994) Annu. Rev. Cell Biol. 10, 87-119[CrossRef]
  9. Poritz, M. A., Bernstein, H. D., Strub, K., Zopf, D., Wilhelm, H., and Walter, P. (1990) Science 250, 1111-1117[Medline] [Order article via Infotrieve]
  10. Brown, S. (1987) Cell 49, 825-833[Medline] [Order article via Infotrieve]
  11. Miller, J. D., Bernstein, H. D., and Walter, P. (1994) Nature 367, 657-659[CrossRef][Medline] [Order article via Infotrieve]
  12. Matlack, K. E. S., Mothes, W., and Rapoport, T. A. (1998) Cell 92, 381-390[Medline] [Order article via Infotrieve]
  13. Lill, R., Cunningham, K., Brundage, L. A., Ito, K., Oliver, D., and Wickner, W. (1989) EMBO J. 8, 961-966[Abstract]
  14. Snyders, S., Ramamurthy, V., and Oliver, D. (1997) J. Biol. Chem. 272, 11302-11306[Abstract/Free Full Text]
  15. Oliver, D. B., and Beckwith, J. (1981) Cell 25, 765-772[Medline] [Order article via Infotrieve]
  16. Cabelli, R. J., Chen, L., Tai, P. C., and Oliver, D. B. (1988) Cell 55, 683-692[Medline] [Order article via Infotrieve]
  17. Hartl, F.-U., Lecker, S., Schiebel, E., Hendrick, J. P., and Wickner, W. (1990) Cell 63, 269-279[Medline] [Order article via Infotrieve]
  18. Schiebel, E., Driessen, A. J. M., Hartl, F.-U., and Wickner, W. (1991) Cell 64, 927-939[Medline] [Order article via Infotrieve]
  19. Economou, A., and Wickner, W. (1994) Cell 78, 835-843[Medline] [Order article via Infotrieve]
  20. Wolfe, P. B., Rice, M., and Wickner, W. (1985) J. Biol. Chem. 260, 1836-1841[Abstract]
  21. Gebert, J. F., Overhoff, B., Manson, M. D., and Boos, W. (1988) J. Biol. Chem. 263, 16652-16660[Abstract/Free Full Text]
  22. Traxler, B., and Murphy, C. (1996) J. Biol. Chem. 271, 12394-12400[Abstract/Free Full Text]
  23. Werner, P. K., Saier, M. H., Jr., and Muller, M. (1992) J. Biol. Chem. 267, 24523-24532[Abstract/Free Full Text]
  24. Bassilana, M., and Gwidzek, C. (1996) EMBO J. 15, 5202-5208[Abstract]
  25. Cabelli, R. J., Dolan, K. M., Qian, L., and Oliver, D. B. (1991) J. Biol. Chem. 266, 24420-24427[Abstract/Free Full Text]
  26. de Gier, J.-W. L., Scotti, P. A., Sääf, A., Valent, Q. A., Kuhn, A., Luirink, J., and von Heijne, G. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 14646-14651[Abstract/Free Full Text]
  27. Oliver, D. B., and Beckwith, J. (1982) Cell 30, 311-319[Medline] [Order article via Infotrieve]
  28. Lee, C. A., and Beckwith, J. (1986) J. Bacteriol. 166, 878-883[Medline] [Order article via Infotrieve]
  29. Miller, J. H. (1992) A Short Course in Bacterial Genetics, Cold Spring Harbor Press, Cold Spring Harbor, NY
  30. Inouye, H., Michaelis, S., Wright, A., and Beckwith, J. (1981) J. Bacteriol. 146, 668-675[Medline] [Order article via Infotrieve]
  31. Newitt, J. A., and Bernstein, H. D. (1998) J. Biol. Chem. 273, 12451-12456[Abstract/Free Full Text]
  32. Filip, C., Fletcher, G., Wulff, J. L., and Earhart, C. F. (1973) J. Bacteriol. 115, 717-722[Medline] [Order article via Infotrieve]
  33. Huffaker, T. C., Hoyt, M. A., and Botstein, D. (1987) Annu. Rev. Genet. 21, 259-284[CrossRef][Medline] [Order article via Infotrieve]
  34. Traxler, B., Lee, C., Boyd, D., and Beckwith, J. (1992) J. Biol. Chem. 267, 5339-5345[Abstract/Free Full Text]
  35. Valent, Q. A., Scotti, P. A., High, S., de Gier, J. W., von Heijne, G., Lentzen, G., Wintermeyer, W., Oudega, B., and Luirink, J. (1998) EMBO J. 17, 2504-2512[Abstract/Free Full Text]
  36. Crowley, K. S., Reinhart, G. D., and Johnson, A. E. (1993) Cell 73, 1101-1115[Medline] [Order article via Infotrieve]
  37. Hegde, R. S., and Lingappa, V. R. (1996) Cell 85, 217-228[Medline] [Order article via Infotrieve]
  38. Hamman, B. D., Hendershot, L. M., and Johnson, A. E. (1998) Cell 92, 747-758[Medline] [Order article via Infotrieve]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.